Results: 24 children and adolescents were studied, 17 of whom were male (70.8%), and the median age was 10.0 (range 3-15) years. Ten (41.7%) had nephrotic syndrome, five (20.8%) had non-nephrotic glomerulonephritis, five (20.8%) were in end-stage renal disease (ESRD), including a patient with posterior urethral valves, and four had acute kidney injury secondary to acute tubular necrosis. Renal histology was available for ten patients: nine had nephrotic syndrome associated with minimal change disease in six, focal segmental glomerulosclerosis in two and one had membanoproliferative glomerulonephritis. The patient with non-nephrotic glomerulonephritis had diffuse global sclerosis.
Introduction

Kidney disease is an important extrahepatic manifestation of hepatitis B virus (HBV)
infection and various forms of glomerular disorders have been described in patients with chronic HBV disease. These include membranous nephropathy, membranoproliferative glomerulonephritis (MPGN), mesangial proliferative glomerulonephritis, immunoglobulin A (IgA) nephropathy, focal segmental glomerulosclerosis (FSGS) and minimal change disease (MCD). 1, 2 The most commonly reported association between HBV and kidney disease in children has been with membranous nephropathy.
1,2
The prevalence of HBV-associated glomerulonephritis tends to parallel the prevalence of HBV infection. HBV-associated glomerular disease has been reported from regions with low, medium and high hepatitis virus endemicity. [3] [4] [5] However, the greatest number of reports, and therefore the sources of greatest detail, are from South-East Asia and South Africa during periods of high regional endemicity of HBV infection. 2, [6] [7] [8] [9] The pattern usually observed in children is that the disease occurs mainly in males and membranous nephropathy is the most common histopathology. Spontaneous regression of nephrotic syndrome, occurs in 30-60%
of patients with HBV membranous nephropathy and it usually coincides with seroconversion of the anti-HBe antigen. The disease, however, runs a benign course in most children and only a minority (1.4-2.8%) progress to end-stage renal disease (ESRD).
It is unclear whether the higher rates of renal disease reported in South Africa and South-East Asia compared with other parts of sub-Saharan Africa are because of better access to facilities for HBV detection and renal investigations rather than a higher prevalence of chronic HBV infection. 10, 11 Additionally, in highly endemic settings, a decline in HBV infection rates and HBV-associated glomerular disease has been recorded following the introduction of universal childhood HBV immunisation. 2 Reports on the prevalence of HBV infection in Nigerian children estimate that the rate of HBsAg seropositivity in children and adolescents was 6.7-40% before introduction of the HBV vaccine into the National Programme on Immunisation in 2004 (Table 1) . A recent metanalysis of prevalence of HBV infection in Nigeria noted a pooled prevalence of 11.5%
in children aged <12 years. 12 The current high prevalence may have been associated with logistical problems associated with ensuring universal and timely immunisation against HBV infection leading to delayed administration of HBV vaccines. [13] [14] [15] Management of several forms of kidney disease in many sub-Saharan African countries is a challenge because of the poor socio-economic conditions. There is limited access to diagnostic facilities, immunosuppressive medication and renal replacement therapy.
Documentation of positive HBsAg in Nigerian children with kidney disease creates additional challenges in terms of the financial burden of laboratory investigations for diagnosing and monitoring the HBV infection, and limited facilities for renal histology. In addition, financial constraints restrict the choice of and access to antiviral agents. These challenges also contribute to limited data on HBV infection and kidney disease in Nigerian children ( Table 2) .
A description of the clinical spectrum of kidney disease in HBsAg-positive patients is an important initial step towards understanding the challenges, designing interventions and assessing the outcome of any interventions. This article reviews the clinical and histological spectrum of kidney disease in HBsAg-positive children and adolescents attending University
College Hospital Ibadan (UCH). 
[t]TABLES 1&2[/t] Methods
Laboratory investigations
HBsAg was determined using third-generation ELISA kits at the Department of Medical Virology, University of Ibadan. Hepatitis B surface antigen status was determined by rapid screening kit in the Department of Haematology, UCH.
At UCH, renal biopsy is usually undertaken in patients with suspected secondary nephrotic syndrome, and in patients with chronic kidney disease (CKD) and non-nephrotic glomerulonephritis (provided they are not in end-stage renal disease or do not have shrunken kidneys on ultrasound). During the study, renal biopsy was sometimes limited by caregivers' financial constraints. In the earlier stage of the study, the non-availability of renal biopsy needles was a barrier. Renal diseases were diagnosed histologically using haematoxylin and eosin stain along with three special stains which were periodic acid schiff (PAS), Masson's trichrome and Jones silver stains. Renal biopsies were analysed by light microscopy only.
Immunofluoresence or electron microscopy was not undertaken on any of the biopsy samples as these facilities are not available. In addition, laboratory investigations and treatment in many patients were limited by financial constraints as payment is usually out-of-pocket. 21 
Definitions
Nephrotic syndrome was defined as massive proteinuria and hypo-albuminaemia with hyperlipidaemia. 22 Massive proteinuria was defined as 24-hour urinary protein >40 mg/m 2 /hour or protein dipstick of ≥3+.
22
Hypertension was defined as blood pressure ≥ 95th percentile for age, gender and height. 23 Non-nephrotic glomerulonephritis consisted of hypertension, azotaemia and proteinuria with or without haematuria. Glomerulonephritis included both nephrotic syndrome and non-nephrotic glomerulonephritis. 22 Chronic kidney disease (CKD) was staged according to the Kidney Disease Improving Global Outcomes (KDIGO) guidelines. 24 In patients with clinical features of septicaemia or haemoglobinuria, acute kidney injury (AKI) was attributed to acute tubular necrosis. ESRD was defined as the need for dialysis or death from renal failure in patients with clinical features of underlying chronic kidney disease.
16,24
Statistical analysis Categorical data were described using proportions. Non-categorical data were analysed as median and range. All analyses were undertaken using the IBM SPSS (International Business
Machines Statistical package for social sciences) data editor version 21.
Ethics approval
Ethics approval was granted by the University of Ibadan/University College Hospital Ethics
Committee. Data were anonymised.
Results
Patients
A total of 24 children and adolescents, 17 male (70.8%), with ages ranging from 3 to 15 years (median 10.0 years ) were studied. Ten (41.4%) had nephrotic syndrome, five (20.8%) had non-nephrotic glomerulonephritis, five (20.8%) were in ESRD, and four (16.7%) had acute kidney injury (AKI) secondary to acute tubular necrosis.
Nephrotic syndrome
The patients with nephrotic syndrome were 3-12 years of age. Eight of the ten were male.
Renal biopsy results were MCD in five, FSGS in two and MPGN in one. Two of the patients with nephrotic syndrome also had CKD stage G3a, and another had CKD stage G2.
Non-nephrotic glomerulonephritis
Five patients had non-nephrotic glomerulonephritis. Three of the patients with non-nephrotic glomerulonephritis had background CKD. Chronic kidney disease was G3a in one of the patients and stage 1 in the other two. One of the patients with CKD had diffuse global sclerosis on renal biopsy. The two other patients had acute glomerulonephritis, one of whom also had clinical features of rapidly progressive glomerulonephritis.
End-stage renal disease
Five other patients were in ESRD when they were found to be HbsAg-positive. One of them had undergone ablation of the posterior urethral valves at the age of 12 years. Another patient had nephrotic syndrome and had defaulted from follow-up for approximately 3 years. Endstage renal disease was secondary to non-nephrotic glomerulonephritis in three patients.
Acute tubular necrosis
Four patients had AKI secondary to acute tubular necrosis. In two, the acute tubular necrosis was secondary to intravascular haemolysis and one other patient had sickle cell anaemia and sepsis.
Discussion
There are few reports on the spectrum of kidney disease in HBsAg-positive Nigerian children. (Table 2 17 The different HBsAg seropositivity in both studies may relate to differences in the study period, study population and prevalence of HBsAg positivity in Lagos and Oyo
States.
There is heterogeneity in the prevalence of HBsAg in different parts of Nigeria, ranging from 0.5 to 46.8 in different parts of the country, as shown in a previous metanalysis 12 and in Table 1 . A recent study from Ibadan showed a low rate of HBsAg seropositivity in children attending a secondary health facility; 25 however, our study was undertaken in a tertiary centre with a potentially higher rate of HBsAg among attendees.
Differences in access to immunisation, sociocultural practices and prevalence of risk factors for vertical and horizontal transmission of HBV infection may account for the differences. Hepatitis B membranous nephropathy usually runs a benign course with only a minority progressing to end-stage renal failure. 2 In this study, however, a relatively high proportion of patients had ESRD. This is consistent with a previous report from Saudi Arabia in which four of seven children with HBV-associated membranous nephropathy developed ESRD. 27 The role of hepatitis B infection in patients with AKI is not clear. Fulminant hepatitis has been associated with AKI, but it was not documented in any of our patients. 28 On the other hand, non-fulminant HBV infection is a rare cause of acute kidney disease. 29 To more accurately delineate the role of hepatitis B infection in children with AKI, additional serology for hepatitis B antigens and antibodies will be required and renal biopsy undertaken in selected patients.
The study has several limitations. To conclude, the spectrum of kidney disease in HBsAg-seropositive children and adolescents in Ibadan is described. Patients with HBsAg will require support in the areas of access to other markers of HBV infection, renal histology and antiviral therapy. Universal immunisation of children to prevent HBV infection and related kidney disease is the ultimate goal. 
